Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir

מאת Gaetano, John N
יצא לאור 2014

Does constipation predict the quality of bowel preparation during colonoscopy?

מאת Bloom, Peter, Shustina, Alexandra, Gaetano, John N, Gualtieri, Nicholas, Tievsky, Dana, Robilotti, James G
הוצא לאור ב Frontline Gastroenterol (2010)

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease

מאת Micic, Dejan, Gaetano, John N., Rubin, Jonah N., Cohen, Russell D., Sakuraba, Atsushi, Rubin, David T., Pekow, Joel
הוצא לאור ב PLoS One (2017)

Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy

מאת Micic, Dejan, Gaetano, John N., Nigam, Neha, Peller, Matthew, Rao, Vijaya L., Semrad, Carol, Stein, Adam C., Kupfer, Sonia S.
הוצא לאור ב PLoS One (2019)

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel di...

מאת Christensen, Britt, Micic, Dejan, Gibson, Peter R., Yarur, Andres, Bellaguarda, Emanuelle, Corsello, Paul, Gaetano, John N., Kinnucan, Jami, Rao, Vijaya L., Reddy, Shilpa, Singh, Samrath, Pekow, Joel, Rubin, David T.
הוצא לאור ב Aliment Pharmacol Ther (2018)